Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

NARecruitingINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Chronic Obstructive Pulmonary Disease SevereInterstitial Lung DiseaseChronic Respiratory Failure With Hypoxia
Interventions
DEVICE

Added high-flow oxygen therapy

Added high-flow oxygen therapy using the device Lumis HFT during nighttime and at the patient's discretion daytime, with the usual care (low-flow oxygen therapy) the rest of the time.

OTHER

Standard care

Standard care with low-flow oxygen therapy in accordance with clinical routine.

Trial Locations (2)

37185

RECRUITING

Research Unit, Blekinge University of Technology, Karlskrona

70185

RECRUITING

Department of Heart, Lung and Clinical Physiology, Örebro University Hospital, Örebro

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

collaborator

Region Stockholm

OTHER_GOV

collaborator

Region Örebro County

OTHER

collaborator

Blekinge County Council Hospital

OTHER

collaborator

Blekinge Institute of Technology

OTHER

collaborator

Lund University

OTHER

collaborator

Region Östergötland

OTHER

collaborator

Vastra Gotaland Region

OTHER_GOV

collaborator

Region Västerbotten

OTHER_GOV

collaborator

Landstinget i Värmland

OTHER

collaborator

ResMed

INDUSTRY

collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

lead

Skane University Hospital

OTHER

NCT06247397 - Effect of HIgh-flow Therapy in Long-term Oxygen Therapy | Biotech Hunter | Biotech Hunter